10th June 2026
What was once largely speculation is now beginning to show up in real sales data. While weight-loss drugs such as Wegovy, Mounjaro and Ozempic are still used by a minority of people, retailers and food manufacturers are already adapting because the changes in shopping habits are becoming measurable.
Smaller shopping baskets
The most obvious effect is that people taking GLP-1 weight-loss drugs generally eat less.
Studies show users often:
buy fewer snacks;
purchase fewer sugary foods;
eat smaller meals;
make fewer impulse purchases.
As a result, supermarkets are beginning to see slightly smaller shopping baskets from these households. Research suggests households using these medicines reduce grocery spending by around 5–11%, although the exact figure varies between studies.
Snacks are under pressure
The biggest losers appear to be products traditionally bought on impulse, including:
crisps;
chocolate;
biscuits;
sweets;
cakes;
sugary drinks.
Kantar found that many GLP-1 users intend to cut back significantly on confectionery and savoury snacks.
That has major implications because these categories have some of the highest profit margins in food retail.
Protein is booming
Interestingly, while people buy less food overall, they are often buying different food.
Doctors and dietitians advise GLP-1 users to increase protein intake to help preserve muscle while losing weight.
Demand has therefore increased for:
Greek yoghurt;
cottage cheese;
eggs;
chicken;
lean meat;
fish;
protein drinks;
protein bars.
The growth in demand has even contributed to a shortage of whey protein, an important ingredient in many high-protein foods and supplements.
Fresh food benefits
Many users report preferring:
fresh fruit;
vegetables;
salads;
smaller ready meals;
healthier ingredients.
Rather than buying large family packs, they often choose smaller portions with better nutritional value.
Supermarkets are adapting
Retailers are responding surprisingly quickly.
Some are:
creating high-protein product ranges;
offering smaller ready meals;
promoting healthier snacks;
reorganising online shopping categories.
Several supermarket executives have confirmed they are closely monitoring GLP-1 trends because they expect the market to keep growing.
Not just supermarkets
The impact extends beyond grocery stores.
Businesses watching the trend include:
fast-food chains;
takeaway operators;
cafés;
confectionery manufacturers;
alcohol producers.
If millions of people permanently consume fewer calories, demand could weaken across many food and drink sectors.
Why investors are paying attention
Financial markets are taking this seriously because food retail operates on very thin margins.
If millions of customers buy:
one fewer chocolate bar,
one fewer bag of crisps,
one fewer frozen pizza,
each week, the effect can be substantial when multiplied across an entire country.
Some analysts now compare the rise of GLP-1 medicines to previous major consumer shifts, such as the move away from smoking or the growth of online shopping.
But there are limits
It is important not to overstate the effect.
Around 4–6% of UK adults are currently estimated to be using GLP-1 medicines, although awareness and uptake continue to rise. Most supermarket customers are not taking these drugs.
Other factors are also shaping grocery sales, including:
food inflation;
the cost-of-living pressures;
changing consumer preferences;
increased health awareness.
Retail experts therefore see weight-loss drugs as accelerating existing trends rather than creating an entirely new market.
The biggest change may still lie ahead. Pharmaceutical companies are developing tablet versions of GLP-1 medicines that could be cheaper and easier to take than injections. If these become widely available over the next few years, usage could expand considerably.
If that happens, supermarkets may need to rethink not only what they stock but how they market food. Rather than focusing on selling larger quantities, retailers may increasingly compete by offering smaller, higher-quality, protein-rich and nutrient-dense products. The result could be a fundamental shift in the grocery market—from a model built on volume and impulse buying to one centred on health, portion control and nutritional value.